Clinical Case Database / Category: Patient Management

Investigations and management of lung cancer

Publication details

M Abeer MRCP, J Morjaria MD, MRCP, Dr JA Kastelik MD, FRCP
Foundation Years Journal, volume 9, issue 4, p.32 (123Doc Education, London, April 2015)

Abstract

Lung cancer is the second most common cancer diagnosed in the UK. The investigations and management of patients with lung cancer remains complex. In the UK it involves a multidisciplinary team approach, which includes close working between respiratory physicians, oncologists, cardiothoracic surgeons, radiologists, histopathologists, palliative care team and specialist nurses. The investigations of patients with lung cancer have also become multifarious, as new technologies such as positron emission tomography scanning, endobronchial or endoscopic ultrasound have acquired wider use. Moreover, the management of patients with lung cancer has become more complex as new chemotherapy and radiotherapy modalities have been developed. The understanding therefore of the modes of presentation of patients with lung cancer is pivotal as it may result in early detection. Moreover the awareness of investigational pathways and therapeutic options remains an important aspect of managing this devastating condition.

Access the Clinical Cases Database

A subscription is required to read the full article. Please subscribe using one of the options below.

Authors

M Abeer MRCP

Department of Respiratory Medicine
Castle Hill Hospital, Castle Road, Cottingham
East Yorkshire HU16 5JQ
Moshfiq.Abeer@hey.nhs.uk

J Morjaria MD, MRCP

Department of Academic Respiratory Medicine
University of Hull, Hull York Medical School
Castle Hill Hospital, Castle Road, Cottingham
East Yorkshire, HU16 5JQ
Jaymin.Morjaria@hey.nhs.uk

Dr JA Kastelik MD, FRCP (Corresponding author)

Department of Respiratory Medicine
Hull University, Hull York Medical School
Castle Hill Hospital, Castle Road, Cottingham
East Yorkshire, HU16 5JQ
jack.kastelik@hey.nhs.uk

References

1. Lung cancer survival statistics. Cancer Research UK. 2013. Available from: http://www.
cancerresearchuk.org/cancer-info/cancerstats/types/lung/survival/lung-cancer-survival-statistics
2. Cancer Research UK. Lung cancer mortality statistics. Trends over time. 2014. Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/lung/mortality/uk-lung-cancer-mortality-statistics.
3. National Institute of Health and Excellence Lung cancer The diagnosis and treatment of lung cancer.Issued: April 2011, NICE clinical guideline 121. Available from: www.nice.org.uk/guidance/cg121
4. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J 2001;18(6):1059-68.
5. Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, Nicholson AG, et al. Non-small-cell lung cancer. Lancet 2011;378:1727-40.
6. Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer 2008;123(1):1-7. doi: 10.1002/ijc.23605
7. Zhang Z, Stiegler AL, Boggon TJ, Kobayashi S, Halmos B. EGFR-mutated lung cancer: a paradigm of molecular oncology. Oncotarget 2010;1:497–514.
8. Mirsadraee S, Oswal D, Alizadeh Y, Caulo A, van Beek E Jr. The 7th lung cancer TNM classification and staging system: Review of the changes and implications. World J Radiol 2012;4(4):128-34. doi: 10.4329/wjr.v4.i4.128.
9. Hamilton W, Peters T J, Round A, Sharp D. What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study. Thorax 2005;60:1059-65.
10. Goulart BHL, Bensink ME, Mummy DG, Ramsey SD. Lung cancer screening with low-dose
computed tomography: Costs, national expenditures, and cost-effectiveness. J Natl Compr Canc Netw2013;11(4):366-7.
11. Buccheri G, Ferrigno D. Lung cancer: Clinical presentation and specialist referral time. Eur Respir J 2004;24:898-904.
12. Jurado Gámez B, García de Lucas MD, Gudín Rodríguez M. Lung cancer and paraneoplastic syndromes. An Med Interna 2001;18:440-6.
13. Boyle P, Chapman CJ, Holdenrieder S, Murray A, Robertson C, Wood WC, et al. Clinical validation of an autoantibody test for lung cancer. Ann Oncol 2011;22:383-9.
14. Del Giudice ME, Young SM, Vella ET, Ash M, Bansal P, Robinson A, Skrastins R, Ung Y, Zeldin R, Levitt C. Systematic review of guidelines for the management of suspected lung cancer in primary care. Can Fam Physician 2014;60(8):e395-404.a
15. British Thoracic Society; Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001;56(2):89-108.
16. Schrevens L, Lorent N, Dooms C, Vansteenkiste J. The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer. Oncologist 2004;9:633-43.
17. Lim E, Baldwin D, Beckles M, Duffy J, Entwisle J, Faivre-Finn C, et al. Guidelines on the radical management of patients with lung cancer. Thorax 2010;65 Suppl 3:iii1-i27.
18. Brunelli A, Charloux A, Bolliger CT, Rocco G, Sculier JP, Varela G, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J 2009;34:17-41.
19. Mauguen A, Le Péchoux C, Saunders MI, Schild SE, Turrisi AT, Baumann M, Sause WT, Ball D, Belani CP, Bonner JA, Zajusz A, Dahlberg SE, Nankivell M, Mandrekar SJ, Paulus R, Behrendt K, Koch R, Bishop JF, Dische S, Arriagada R, De Ruysscher D, Pignon JP. Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis. J Clin Oncol 2012;30(22):2788-97. doi: 10.1200/JCO.2012.41.6677.
20. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303(11):1070-6. doi: 10.1001/jama.2010.261
21. Argiris A, Murren JR. Staging and clinical prognostic factors for small-cell lung cancer. Cancer J 2001;7:437-47.
22. Lüchtenborg M, Riaz SP, Lim E, Page R, Baldwin DR, Jakobsen E, Vedsted P, Lind M, Peake MD, Mellemgaard A, Spicer J, Lang-Lazdunski L, Møller H. Survival of patients with small cell lung cancer undergoing lung resection in England, 1998-2009. Thorax 2014;69(3):269-73. doi: 10.1136/ thoraxjnl-2013-203884.
23. Slotman B, Faivre-Finn C, Kramer G, Rankin E, Snee M, Hatton M, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007;357(7):664-72.
24. Zhu C-Q, Ding K, Strumpf D, Weir BA, Meyerson M, Pennell N, et al. Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. J Clin Oncol 2010;28:4417-24.
25. Fielding DI, Kurimoto N. EBUS-TBNA/Staging of Lung Cancer. Clin Chest Med 2013;34(3):385-94. doi: 10.1016/j.ccm.2013.06.003.
26. Moore S. Guidelines on the role of the specialist nurse in supporting patients with lung cancer. Eur J Cancer Care (Engl) 2004;13(4):344-8.

Disclaimers

Conflict Of Interest

The Journal requires that authors disclose any potential conflict of interest that they may have. This is clearly stated in the Journal’s published “Guidelines for Authors”. The Journal follows the Guidelines against Conflict of Interest published in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/urm_full.pdf).

Financial Statement

The authors of this article have not been paid. The Journal is financed by subscriptions and advertising. The Journal does not receive money from any other sources. The decision to accept or refuse this article for publication was free from financial considerations and was solely the responsibility of the Editorial Panel and Editor-in-Chief.

Patient Consent statement

All pictures and investigations shown in this article are shown with the patients’ consent. We require Authors to maintain patients’ anonymity and to obtain consent to report investigations and pictures involving human subjects when anonymity may be compromised. The Journal follows the Guidelines of the Uniform Requirements for Manuscripts (http://www.icmje.org/urm_full.pdf). The Journal requires in its Guidelines for Authors a statement from Authors that “the subject gave informed consent”.

Animal & Human Rights

When reporting experiments on human subjects, the Journal requires authors to indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the HelsinkiDeclaration of 1975, as revised in 2008.

About the Clinical Cases Database

T​he Foundation Years Clinical Cases Database is​ a selection of 600 peer-reviewed clinical cases in the field of patient safety and clinical practice, specifically focused on the clinical information needs of junior doctors, based around the Foundation Year Curriculum programme (MMC). The cases have been chosen to align with the Foundation Year Curriculum.

The database is fully searchable, or can be browsed by medical specialty. Abstracts can be read free of charge, however a subscription is required in order to read the complete cases.